What is the Share Price of Divis Laboratories Ltd?

Divis Laboratories Ltd share price is ₹5,750.10 As on 17 November, 2024|21:29

Home
>
Stocks
>
Divis Laboratories Ltd

Divis Laboratories Ltd Share/Stock Price

Q: What is the Market Cap of Divis Laboratories Ltd?

The Market Cap of Divis Laboratories Ltd is ₹152,647 As on 17 November, 2024|21:29

Q: What is PE Ratio of Divis Laboratories Ltd?

The P/E ratio of Divis Laboratories Ltd is 83.1 As on 17 November, 2024|21:29

Q: What is PB Ratio of Divis Laboratories Ltd?

The PB ratio of Divis Laboratories Ltd is 11.12 As on 17 November, 2024|21:29

₹ 5,750.10 -20.00 (-0.35%)
Updated on 17-11-2024 6:56 AM

Stock Rating

Pros 5

Cons 3

Option Chain

Divis Laboratories Ltd Price Performance

Day's Low
₹5,723.15

Day's High
₹5,825.95

₹ 5,750.10

52-w low
₹3,350

52-w high
₹6,275.85

5,750.10

Day's open
₹5,770.10
Previous close
₹5,770.10
VWAP
₹5,764.98
Lower price band
₹5,175.10
Upper price band
₹6,325.10

Today's Market Action

The last traded share price of Divis Laboratories Ltd was 5,750.10 down by -0.35% on the NSE. Its last traded stock price on BSE was 5,745.35 down by -0.48%. The total volume of shares on NSE and BSE combined was 220,287 shares. Its total combined turnover was Rs 127.00 crores.

Divis Laboratories Ltd Medium and Long Term Market Action

Divis Laboratories Ltd hit a 52-week high of 6,275.85 on 15-10-2024 and a 52-week low of 3,350 on 27-03-2024. The stock price of Divis Laboratories Ltd is down by -4% over the last one month. It is up by 61.97% over the last one year. Don't forget to check the full stock price history in the table below.

Divis Laboratories Ltd Fundamentals

Market Cap (Cr): 152647
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Divis Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Divis Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Divis Laboratories Ltd

Data not available.

Divis Laboratories Ltd FAQ's

What is Share Price of Divis Laboratories Ltd?

What is the Market Cap of Divis Laboratories Ltd?

What is PE Ratio of Divis Laboratories Ltd?

What is PB Ratio of Divis Laboratories Ltd?

What is the CAGR of Divis Laboratories Ltd?

How to Buy Divis Laboratories Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.25. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 262 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(17/11/2024)

Margin of Safety Index: Moderate

74.36%

74.36% People are bullish about Divis Laboratories Ltd

25.64%

25.64 % People are bearish about Divis Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %